| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |